Jump Financial, LLC Bridge Bio Pharma, Inc. Transaction History

Jump Financial, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	$13.29 - $18.01 $168,822 - $228,781	12,703 New	12,703 $218,000
Q2 2023 Aug 07, 2023	BUY	$13.29 - $18.01 $168,822 - $228,781	12,703 New	12,703 $218,000
Q3 2022 Nov 07, 2022	BUY	$7.94 - $12.36 $754,268 - $1.17 Million	94,996 New	94,996 $944,000
Q2 2022 Aug 09, 2022	SELL	$5.21 - $12.14 $795,546 - $1.85 Million	-152,696 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$7.34 - $17.16 $1.12 Million - $2.62 Million	152,696 New	152,696 $1.55 Million
Q4 2021 Feb 10, 2022	SELL	$11.38 - $53.41 $170,768 - $801,470	-15,006 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $703,331 - $963,985	15,006 New	15,006 $703,000
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $998,460 - $1.3 Million	-18,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $242,254 - $448,846	6,312 Added 54.0%	18,000 $1.28 Million
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $317,913 - $493,116	11,688 New	11,688 $439,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.